You are here: Industry Insights > FDA

News List

B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site contractpharma
February 03, 2022
Increased availability of IV solutions to address shortages stemming from ongoing COVID-19 crisis.
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice FirstWordPharma
January 29, 2022
Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment of patients...
FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion prnasia
January 28, 2022
Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment...
FDA issues series of guidances under Drug Competition Action Plan FDA
January 28, 2022
This week, FDA published a series of guidances focused on generic drug application submissions, labeling, and review. These guidances are part of our continued efforts to bring greater efficiency and transparency to the generic drug review process...
Roche gets FDA priority review for Evrysdi to treat SMA in new-borns pharmaceutical-business-review
January 27, 2022
Swiss healthcare company Roche has received the US Food and Drug Administration (FDA) priority review for its Evrysdi...
Labnovation's COVID-19 ART Test Kit, Imported by Clearbridge, is One of the Only Two COVID-19 ART Test Kits in the Philippines Approved by the FDA of the Philippines for Self-Testing PharmaSources.com
January 27, 2022
Asia's integrated healthcare company, Clearbridge Health Limited ("Clearbridge" or the "Company" and together...
FDA limits usage of Lilly and Regeneron’s monoclonal antibodies for Covid-19 Pharmaceutical-Technology
January 26, 2022
The move comes after data showed these therapies are highly unlikely to be active against the Omicron variant.
FDA issues complete response letter for Merck’s chronic cough treatment Pharmaceutical-Technology
January 26, 2022
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Merck’s (MSD) New Drug Application (NDA) for gefapixant to treat adults with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
FDA Purchases Software from Waters to Support its Medical Testing Labs contractpharma
January 26, 2022
Will speed data retrieval, automate essential audit and archival functions, and ensure compliance with legislative mandates.
FDA Halts Use of Regeneron, Lilly COVID Antibody Therapies contractpharma
January 25, 2022
Cites the therapies are less able to target Omicron because of its mutations.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page